Alloy vs Marek Health

Vial Take

Both Alloy and Marek Health are clean telehealth platforms with no federal red flags across FDA, OIG, DEA, and HIPAA checks, so the baseline safety picture is solid for either. Where they split: Marek discloses its pharmacy partners (Empower and Fagron), giving you a clearer view of the medication supply chain, while Alloy leaves that piece undisclosed, which is the main question you'll want answered before committing. Alloy's edge is physician specialization, with OB/GYN credentials focused specifically on menopause that outrun Marek's more generalist clinical team description, so if women's hormonal health is your focus, Alloy's clinical depth is real, but Marek's supply chain transparency and slightly higher trust score tip the scales for verifiability.

Biggest Differences

1. 1
   Pharmacy disclosure
   Marek Health publishes its compounding partners (Empower Pharmacy, Fagron), so you can verify the supply chain; Alloy does not name a pharmacy partner publicly.
2. 2
   Geographic reach
   Marek Health is available in 45 states compared to Alloy's 0, which may decide the question before any other signal if you're outside Alloy's footprint.
3. 3
   Trust Score gap (5 points)
   Marek Health scores 80/100 to Alloy's 75/100, a 5-point spread driven by the differences below.